The FDA has approved repotrectinib (Augtyro) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer. SUMMARY: The Food and Drug Administration (FDA) recently approved a new drug called repotrectinib for treating a…
Summary: This article discusses recent clinical research showing the benefits of genomic testing (biomarker testing) for patients with non-small cell lung cancer (NSCLC). Genomic testing analyzes the DNA of a tumor to identify specific gene mutations that are driving…
Summary The Stephenson Cancer Center at the University of Oklahoma is acquiring a mobile CT scanner that can screen for lung cancer. The scanner will be housed in a large RV and driven to rural communities to provide potentially…
Summary: A recent multicenter study published in The Lancet highlights the promising efficacy of immunotherapy in advanced lung cancer patients. The study, conducted across multiple institutions, aimed to evaluate the effectiveness of immune checkpoint inhibitors in treating patients with…
SUMMARY: The Monarch Platform robotic tool has revolutionized the way lung cancer is diagnosed and treated at Baptist Health. This cutting-edge technology provides a real-time, high-definition view of the airways, enabling doctors to identify and biopsy suspicious lung nodules…
SUMMARY: A recent study has shown that treatment with Rybrevant (amivantamab-vmjw) in combination with chemotherapy has resulted in a significant improvement in progression-free survival for patients with newly diagnosed EGFR exon 20 insertion mutations. The study, published in the…
SUMMARY: A recent study has found that consuming substantial meals can significantly increase the concentration of lung cancer drugs in the body. The research, published in the journal Cure, highlights the potential impact of meal timing on the effectiveness…
SUMMARY: A recent study sheds light on the challenges faced by black veterans when it comes to receiving timely referrals for lung cancer. The study, conducted by researchers from the University of Michigan and the VA Ann Arbor Healthcare…
SUMMARY: Dr. Steven Dubinett, member of LCFA’s Scientific Advisory Board, has been appointed as the new Dean of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). In this role, Dr. Dubinett will oversee…
SUMMARY: Bristol-Myers Squibb (BMS) recently presented promising findings from a four-year study on the combination therapy has shown significant potential in improving outcomes for patients with advanced non-small cell lung cancer (NSCLC). The Phase 3 CheckMate-9LA is a clinical…